Influenza Vaccine



Combined with:

Indications and Reactions:

Role Indications Reactions
Primary
Product Used For Unknown Indication 37.5%
Prophylaxis 18.8%
H1n1 Influenza 12.5%
Asthma 6.3%
Benign Prostatic Hyperplasia 6.3%
Blood Cholesterol 6.3%
Immunisation 6.3%
Multiple Allergies 6.3%
Dyspnoea 25.0%
Pneumonia 25.0%
Quality Of Life Decreased 25.0%
Weight Decreased 25.0%
Secondary
Product Used For Unknown Indication 33.4%
Drug Use For Unknown Indication 9.4%
Immunisation 8.6%
Prophylaxis 5.9%
Drug Exposure During Pregnancy 5.5%
Hypertension 5.1%
Diffuse Large B-cell Lymphoma 4.7%
Rheumatoid Arthritis 4.5%
Influenza Immunisation 2.9%
Rectal Cancer 2.9%
Maternal Exposure During Pregnancy 2.7%
Paroxysmal Nocturnal Haemoglobinuria 2.0%
Schizophrenia 2.0%
Asthma 1.8%
Pain 1.8%
Antiviral Prophylaxis 1.6%
Dry Skin 1.6%
Pyrexia 1.6%
Bronchiectasis 1.2%
Crohn's Disease 1.2%
Urticaria 9.6%
Vomiting 9.6%
Pyrexia 6.8%
Interstitial Lung Disease 5.5%
Myositis 5.5%
Swelling 5.5%
Syncope 5.5%
Death 4.1%
Drug Hypersensitivity 4.1%
Influenza Like Illness 4.1%
Loss Of Consciousness 4.1%
Multi-organ Failure 4.1%
Nasopharyngitis 4.1%
Nausea 4.1%
Rash 4.1%
Talipes 4.1%
Tourette's Disorder 4.1%
Urinary Tract Infection 4.1%
Wrong Technique In Drug Usage Process 4.1%
Cough 2.7%
Concomitant
Product Used For Unknown Indication 31.4%
Drug Use For Unknown Indication 15.4%
Rheumatoid Arthritis 7.8%
Hypertension 7.1%
Multiple Myeloma 5.8%
Pain 4.4%
Prophylaxis 4.4%
Depression 2.5%
Asthma 2.5%
Crohn's Disease 2.5%
Osteoporosis 2.0%
Prostate Cancer 2.0%
Anaemia 1.9%
Vitamin Supplementation 1.6%
Back Pain 1.6%
Type 2 Diabetes Mellitus 1.5%
Immunisation 1.5%
Influenza Immunisation 1.5%
Metastases To Bone 1.4%
Constipation 1.3%
Wheezing 11.0%
Weight Decreased 10.7%
Vomiting 10.4%
White Blood Cell Count Decreased 7.2%
Therapeutic Response Decreased 6.3%
Pyrexia 5.1%
Weight Increased 4.8%
Pneumonia 4.5%
Thrombocytopenia 4.5%
Wound 4.2%
Swelling Face 3.9%
Nausea 3.6%
X-ray Abnormal 3.6%
Tremor 3.3%
Headache 3.0%
Pain In Extremity 3.0%
Tooth Extraction 3.0%
Malaise 2.7%
Rheumatoid Arthritis 2.7%
Viral Pharyngitis 2.7%
Interacting
Drug Use For Unknown Indication 66.7%
Hypertension 13.3%
Product Used For Unknown Indication 13.3%
Pain 6.7%
Drug Interaction 28.6%
Renal Pain 28.6%
Fatigue 14.3%
Haemorrhage Intracranial 14.3%
Hypoglycaemic Coma 14.3%